Insmed Historical Balance Sheet

INSM Stock

USD 79.92 1.15 1.46%

Trend analysis of Insmed Inc balance sheet accounts such as Total Current Liabilities of 312.4 M or Total Stockholder Equity of 299.6 M provides information on Insmed's total assets, liabilities, and equity, which is the actual value of Insmed Inc to its prevalent stockholders. By breaking down trends over time using Insmed balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Insmed Inc latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Insmed Inc is a good buy for the upcoming year.

Insmed Inventory

103.51 Million

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Insmed Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

About Insmed Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Insmed Inc at a specified time, usually calculated after every quarter, six months, or one year. Insmed Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Insmed and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Insmed currently owns. An asset can also be divided into two categories, current and non-current.

Insmed Balance Sheet Chart

At this time, Insmed's Cash is very stable compared to the past year. As of the 23rd of March 2025, Non Current Assets Total is likely to grow to about 423.7 M, though Retained Earnings are likely to grow to (4.1 B).

Total Assets Other Current Liab Total Current Liabilities Property Plant And Equipment Net Retained Earnings

Add Fundamental

Total Assets

Total assets refers to the total amount of Insmed assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Insmed Inc books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Insmed balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Insmed Inc are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Property Plant And Equipment Net

The total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects the company's investment in assets used for production.

Retained Earnings

The cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends.

Most accounts from Insmed's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Insmed Inc current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Insmed Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

	2022	2023	2024	2025 (projected)
Other Current Liabilities	131.7M	149.6M	212.2M	222.8M
Total Assets	1.7B	1.3B	2.0B	2.1B

Other Current Liab Total Assets

Insmed balance sheet Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Common Stock Total Equity	Common Stock Shares Outstanding	Short Term Investments	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Common Stock	Other Liab	Other Assets	Good Will	Non Current Liabilities Total	Intangible Assets
Total Assets		0.95	0.98	0.08	0.89	-0.13	-0.98	0.96	0.8	0.95	0.95	0.99	0.83	0.97	0.79	0.77	0.98	0.97	0.93	1.0	0.97	0.89	0.91	0.93	0.96	0.44
Other Current Liab	0.95		0.98	-0.06	0.76	-0.1	-0.96	0.97	0.65	0.88	0.95	0.95	0.73	0.92	0.88	0.65	0.95	0.96	0.86	0.96	0.93	0.83	0.88	0.92	0.95	0.36
Total Current Liabilities	0.98	0.98		-0.03	0.88	-0.08	-0.99	0.98	0.71	0.93	0.97	0.97	0.8	0.96	0.85	0.74	0.99	0.98	0.95	0.98	0.97	0.85	0.92	0.91	0.97	0.37
Total Stockholder Equity	0.08	-0.06	-0.03		0.05	-0.86	0.02	-0.08	0.17	-0.03	-0.19	0.13	0.03	0.08	0.04	0.31	0.11	-0.16	-0.03	0.12	0.09	0.03	-0.04	-0.01	-0.19	0.2
Property Plant And Equipment Net	0.89	0.76	0.88	0.05		0.04	-0.89	0.86	0.8	0.9	0.86	0.85	0.83	0.89	0.58	0.85	0.88	0.87	0.97	0.87	0.89	0.79	0.86	0.75	0.86	0.34
Net Debt	-0.13	-0.1	-0.08	-0.86	0.04		0.05	0.0	0.01	0.09	0.12	-0.22	0.09	-0.09	-0.35	-0.12	-0.18	0.08	0.02	-0.19	-0.11	0.04	-0.03	-0.02	0.11	0.02
Retained Earnings	-0.98	-0.96	-0.99	0.02	-0.89	0.05		-0.98	-0.72	-0.94	-0.97	-0.96	-0.84	-0.98	-0.82	-0.76	-0.99	-0.97	-0.96	-0.97	-0.98	-0.86	-0.93	-0.91	-0.97	-0.41
Accounts Payable	0.96	0.97	0.98	-0.08	0.86	0.0	-0.98		0.7	0.92	0.97	0.94	0.81	0.95	0.8	0.76	0.96	0.97	0.93	0.95	0.96	0.83	0.9	0.89	0.96	0.37
Cash	0.8	0.65	0.71	0.17	0.8	0.01	-0.72	0.7		0.8	0.7	0.79	0.85	0.79	0.29	0.74	0.73	0.75	0.71	0.79	0.79	0.74	0.77	0.7	0.75	0.53
Non Current Assets Total	0.95	0.88	0.93	-0.03	0.9	0.09	-0.94	0.92	0.8		0.96	0.91	0.85	0.93	0.66	0.81	0.92	0.95	0.92	0.92	0.93	0.96	0.84	0.95	0.95	0.52
Non Currrent Assets Other	0.95	0.95	0.97	-0.19	0.86	0.12	-0.97	0.97	0.7	0.96		0.92	0.79	0.92	0.78	0.7	0.94	0.99	0.93	0.93	0.93	0.89	0.87	0.93	0.99	0.38
Cash And Short Term Investments	0.99	0.95	0.97	0.13	0.85	-0.22	-0.96	0.94	0.79	0.91	0.92		0.8	0.95	0.82	0.73	0.98	0.95	0.9	1.0	0.96	0.84	0.91	0.9	0.94	0.42
Common Stock Total Equity	0.83	0.73	0.8	0.03	0.83	0.09	-0.84	0.81	0.85	0.85	0.79	0.8		0.88	0.44	0.76	0.81	0.81	0.81	0.81	0.87	0.75	0.83	0.76	0.81	0.56
Common Stock Shares Outstanding	0.97	0.92	0.96	0.08	0.89	-0.09	-0.98	0.95	0.79	0.93	0.92	0.95	0.88		0.75	0.79	0.98	0.94	0.94	0.96	1.0	0.83	0.94	0.9	0.93	0.51
Short Term Investments	0.79	0.88	0.85	0.04	0.58	-0.35	-0.82	0.8	0.29	0.66	0.78	0.82	0.44	0.75		0.43	0.84	0.78	0.74	0.82	0.76	0.62	0.7	0.75	0.76	0.15
Other Current Assets	0.77	0.65	0.74	0.31	0.85	-0.12	-0.76	0.76	0.74	0.81	0.7	0.73	0.76	0.79	0.43		0.78	0.69	0.8	0.74	0.78	0.8	0.66	0.68	0.67	0.38
Other Stockholder Equity	0.98	0.95	0.99	0.11	0.88	-0.18	-0.99	0.96	0.73	0.92	0.94	0.98	0.81	0.98	0.84	0.78		0.95	0.94	0.98	0.99	0.85	0.92	0.91	0.93	0.42
Total Liab	0.97	0.96	0.98	-0.16	0.87	0.08	-0.97	0.97	0.75	0.95	0.99	0.95	0.81	0.94	0.78	0.69	0.95		0.93	0.96	0.94	0.87	0.91	0.92	1.0	0.39
Property Plant And Equipment Gross	0.93	0.86	0.95	-0.03	0.97	0.02	-0.96	0.93	0.71	0.92	0.93	0.9	0.81	0.94	0.74	0.8	0.94	0.93		0.92	0.94	0.81	0.89	0.82	0.92	0.32
Total Current Assets	1.0	0.96	0.98	0.12	0.87	-0.19	-0.97	0.95	0.79	0.92	0.93	1.0	0.81	0.96	0.82	0.74	0.98	0.96	0.92		0.97	0.85	0.91	0.91	0.95	0.41
Common Stock	0.97	0.93	0.97	0.09	0.89	-0.11	-0.98	0.96	0.79	0.93	0.93	0.96	0.87	1.0	0.76	0.78	0.99	0.94	0.94	0.97		0.84	0.94	0.9	0.93	0.5
Other Liab	0.89	0.83	0.85	0.03	0.79	0.04	-0.86	0.83	0.74	0.96	0.89	0.84	0.75	0.83	0.62	0.8	0.85	0.87	0.81	0.85	0.84		0.72	0.93	0.87	0.49
Other Assets	0.91	0.88	0.92	-0.04	0.86	-0.03	-0.93	0.9	0.77	0.84	0.87	0.91	0.83	0.94	0.7	0.66	0.92	0.91	0.89	0.91	0.94	0.72		0.79	0.9	0.35
Good Will	0.93	0.92	0.91	-0.01	0.75	-0.02	-0.91	0.89	0.7	0.95	0.93	0.9	0.76	0.9	0.75	0.68	0.91	0.92	0.82	0.91	0.9	0.93	0.79		0.92	0.62
Non Current Liabilities Total	0.96	0.95	0.97	-0.19	0.86	0.11	-0.97	0.96	0.75	0.95	0.99	0.94	0.81	0.93	0.76	0.67	0.93	1.0	0.92	0.95	0.93	0.87	0.9	0.92		0.39
Intangible Assets	0.44	0.36	0.37	0.2	0.34	0.02	-0.41	0.37	0.53	0.52	0.38	0.42	0.56	0.51	0.15	0.38	0.42	0.39	0.32	0.41	0.5	0.49	0.35	0.62	0.39

Click cells to compare fundamentals

Insmed Account Relationship Matchups

Insmed balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	796.2M	1.2B	1.7B	1.3B	2.0B	2.1B
Other Current Liab	50.8M	79.1M	131.7M	149.6M	212.2M	222.8M
Total Current Liabilities	118.8M	135.2M	190.2M	225.6M	297.5M	312.4M
Total Stockholder Equity	275.9M	410.5M	88.0M	(331.9M)	285.4M	299.6M
Property Plant And Equipment Net	97.2M	95.5M	102.1M	104.4M	115.6M	121.4M
Net Debt	(127.9M)	(104.5M)	103.8M	721.6M	(509.5M)	(484.1M)
Retained Earnings	(1.8B)	(2.3B)	(2.7B)	(3.4B)	(4.4B)	(4.1B)
Accounts Payable	42.9M	35.8M	50.5M	65.4M	73.0M	76.7M
Cash	532.8M	716.8M	1.1B	482.4M	555.0M	582.8M
Non Current Assets Total	173.3M	406.5M	383.1M	400.8M	403.6M	423.7M
Non Currrent Assets Other	26.8M	51.0M	76.1M	96.6M	93.2M	97.9M
Cash And Short Term Investments	532.8M	716.8M	1.1B	780.4M	1.4B	1.5B
Common Stock Total Equity	897K	1.0M	1.2M	1.4M	1.6M	804.3K
Common Stock Shares Outstanding	97.6M	112.1M	123.0M	140.4M	164.0M	172.2M
Liabilities And Stockholders Equity	796.2M	1.2B	1.7B	1.3B	2.0B	2.1B
Other Current Assets	48.0M	57.8M	25.5M	24.2M	37.2M	39.1M
Other Stockholder Equity	2.1B	2.7B	2.8B	3.1B	4.6B	4.9B
Total Liab	520.3M	833.0M	1.6B	1.7B	1.7B	1.8B
Property Plant And Equipment Gross	97.2M	95.5M	102.1M	149.0M	165.9M	174.2M
Total Current Assets	622.9M	837.0M	1.3B	929.1M	1.6B	1.7B
Accumulated Other Comprehensive Income	193K	968K	756K	(745K)	(2.3M)	(2.2M)
Common Stock	1.0M	1.2M	1.4M	1.5M	1.8M	1.9M
Other Assets	72.5M	70.0M	51.0M	113.7M	130.7M	137.3M
Good Will	58.7M	53.7M	49.3M	136.1M	156.5M	164.4M
Non Current Liabilities Total	401.5M	697.9M	1.4B	1.4B	1.4B	1.5B
Intangible Assets	49.3M	73.8M	68.8M	63.7M	58.7M	61.5M
Property Plant Equipment	60.2M	54.0M	53.0M	56.5M	65.0M	68.2M
Net Receivables	16.6M	24.4M	29.7M	41.2M	52.0M	54.6M
Short Term Debt	25.1M	20.3M	8.1M	10.6M	12.3M	14.1M
Short Long Term Debt Total	404.8M	612.3M	1.2B	1.2B	45.5M	43.2M
Long Term Debt	356.3M	566.6M	1.1B	1.2B	1.1B	1.2B
Inventory	49.6M	67.0M	69.9M	83.2M	98.6M	103.5M
Net Tangible Assets	208.0M	226.6M	200.5M	(116.9M)	(134.5M)	(127.7M)
Retained Earnings Total Equity	(1.5B)	(1.8B)	(2.3B)	(2.7B)	(2.4B)	(2.3B)
Capital Surpluse	1.8B	2.1B	2.7B	2.8B	3.2B	3.4B
Deferred Long Term Liab	52.1M	47.3M	72.0M	37.6M	43.2M	45.7M
Non Current Liabilities Other	45.1M	131.3M	208.5M	242.8M	305.8M	321.1M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Insmed Inc is a strong investment it is important to analyze Insmed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Insmed's future performance. For an informed investment choice regarding Insmed Stock, refer to the following important reports:

How To Invest In Insmed

Details

Is Insmed Stock a good investment?

Details

What is Insmed's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Insmed. If investors know Insmed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Insmed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(5.57)

Revenue Per Share

2.217

Quarterly Revenue Growth

0.248

Return On Assets

(0.29)

Return On Equity

(8.91)

The market value of Insmed Inc is measured differently than its book value, which is the value of Insmed that is recorded on the company's balance sheet. Investors also form their own opinion of Insmed's value that differs from its market value or its book value, called intrinsic value, which is Insmed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Insmed's market value can be influenced by many factors that don't directly affect Insmed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Insmed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Insmed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Insmed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Insmed Historical Balance Sheet

Insmed Inventory

103.51 Million

About Insmed Balance Sheet Analysis

Insmed Balance Sheet Chart

Total Assets

Total Current Liabilities

Property Plant And Equipment Net

Retained Earnings

Insmed balance sheet Correlations

Insmed Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Insmed balance sheet Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Cash And Short Term Investments
Common Stock	+ 1.0	Common Stock Shares Outstanding
Non Current Liabilities Total	+ 1.0	Total Liab
Cash And Short Term Investments	+ 0.99	Total Assets
Other Stockholder Equity	+ 0.99	Total Current Liabilities

Other Stockholder Equity	- 0.99	Retained Earnings
Retained Earnings	- 0.99	Total Current Liabilities
Common Stock	- 0.98	Retained Earnings
Common Stock Shares Outstanding	- 0.98	Retained Earnings
Accounts Payable	- 0.98	Retained Earnings
Retained Earnings	- 0.98	Total Assets